{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:32:06Z","timestamp":1791415926026,"version":"4.3.3"},"reference-count":62,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,5,15]]},"abstract":"<jats:p>Saliva of the hard tick and Lyme disease vector, Ixodes scapularis, has a repertoire of compounds that counteract host defenses. Following sequencing of an I scapularis salivary gland complementary DNA (cDNA) library, a clone with sequence homology to tissue factor pathway inhibitor (TFPI) was identified. This cDNA codes for a mature protein, herein called Ixolaris, with 140 amino acids containing 10 cysteines and 2 Kunitz-like domains. Recombinant Ixolaris was expressed in insect cells and shown to inhibit factor VIIa (FVIIa)\/tissue factor (TF)\u2013induced factor X (FX) activation with an inhibitory concentration of 50% (IC50) in the picomolar range. In nondenaturing gel, Ixolaris interacted stoichiometrically with FX and FXa but not FVIIa. Ixolaris behaves as a fast-and-tight ligand of the exosites of FXa and \u03b3-carboxyglutamic acid domainless FXa (des-Gla-FXa), increasing its amidolytic activity. At high concentration, Ixolaris attenuates the amidolytic activity of FVIIa\/TF; however, in the presence of DEGR-FX or DEGR-FXa (but not des-Gla-DEGR-FXa), Ixolaris becomes a tight inhibitor of FVIIa\/TF as assessed by recombinant factor IX (BeneFIX) activation assays. This indicates that FX and FXa are scaffolds for Ixolaris in the inhibition of FVIIa\/TF and implies that the Gla domain is necessary for FVIIa\/TF\/Ixolaris\/FX(a) complex formation. Additionally, we show that Ixolaris blocks FXa generation by endothelial cells expressing TF. Ixolaris may be a useful tool to study the structural features of FVIIa, FX, and FXa, and an alternative anticoagulant in cardiovascular diseases.<\/jats:p>","DOI":"10.1182\/blood-2001-12-0237","type":"journal-article","created":{"date-parts":[[2002,10,11]],"date-time":"2002-10-11T18:33:52Z","timestamp":1034361232000},"page":"3602-3612","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":231,"title":["Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa\/tissue factor complex"],"prefix":"10.1182","volume":"99","author":[{"given":"Ivo M. B.","family":"Francischetti","sequence":"first","affiliation":[{"name":"From the Section of Medical Entomology, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, and Center for Vector-Borne Disease, University of Rhode Island, Kingston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus G.","family":"Valenzuela","sequence":"additional","affiliation":[{"name":"From the Section of Medical Entomology, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, and Center for Vector-Borne Disease, University of Rhode Island, Kingston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Andersen","sequence":"additional","affiliation":[{"name":"From the Section of Medical Entomology, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, and Center for Vector-Borne Disease, University of Rhode Island, Kingston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N.","family":"Mather","sequence":"additional","affiliation":[{"name":"From the Section of Medical Entomology, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, and Center for Vector-Borne Disease, University of Rhode Island, Kingston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose\u0301 M. C.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"From the Section of Medical Entomology, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, and Center for Vector-Borne Disease, University of Rhode Island, Kingston."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021219441875300_B1","first-page":"77","article-title":"Tissue factor pathway inhibitor.","volume-title":"Thrombosis and Hemorrhage.","author":"Broze","year":"1998","edition":"2nd ed."},{"key":"2020021219441875300_B2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood.V71.2.335.335","article-title":"The lipoprotein-associated coagulation inhibitor that inhibits the FVII-tissue factor complex also inhibits FXa: insight into its possible mechanism of action.","volume":"71","author":"Broze","year":"1988","journal-title":"Blood."},{"key":"2020021219441875300_B3","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V69.2.645.645","article-title":"Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation.","volume":"69","author":"Rao","year":"1987","journal-title":"Blood."},{"key":"2020021219441875300_B4","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1073\/pnas.84.7.1886","article-title":"Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cells.","volume":"84","author":"Broze","year":"1987","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021219441875300_B5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1182\/blood.V73.2.359.359","article-title":"Inhibition of FVIIa\/tissue factor-induced blood coagulation: with particular emphasis upon a FXa-dependent inhibitory mechanism.","volume":"73","author":"Rapaport","year":"1989","journal-title":"Blood."},{"key":"2020021219441875300_B6","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1016\/S0021-9258(18)68737-X","article-title":"Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.","volume":"263","author":"Wun","year":"1988","journal-title":"J Biol Chem."},{"key":"2020021219441875300_B7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/338518a0","article-title":"Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.","volume":"338","author":"Girard","year":"1989","journal-title":"Nature."},{"key":"2020021219441875300_B8","doi-asserted-by":"crossref","first-page":"26950","DOI":"10.1016\/S0021-9258(19)74202-1","article-title":"Kinetics of FXa inhibition by tissue factor pathway inhibitor.","volume":"268","author":"Huang","year":"1993","journal-title":"J Biol Chem."},{"key":"2020021219441875300_B9","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1055\/s-0038-1649846","article-title":"Kinetics of the inhibition of tissue factor-FVIIa by tissue factor pathway inhibitor.","volume":"74","author":"Lindhout","year":"1995","journal-title":"Thromb Haemost."},{"key":"2020021219441875300_B10","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.1016\/S0021-9258(18)52932-X","article-title":"Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI).","volume":"268","author":"Hamamoto","year":"1993","journal-title":"J Biol Chem."},{"key":"2020021219441875300_B11","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1021\/bi00485a001","article-title":"Regulation of coagulation by multivalent Kunitz-type inhibitor.","volume":"29","author":"Broze","year":"1995","journal-title":"Biochemistry."},{"key":"2020021219441875300_B12","doi-asserted-by":"crossref","first-page":"10867","DOI":"10.1021\/bi00034a020","article-title":"Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor-VIIa with Xa-tissue factor pathway inhibitor.","volume":"34","author":"Rao","year":"1995","journal-title":"Biochemistry."},{"key":"2020021219441875300_B13","doi-asserted-by":"crossref","first-page":"16786","DOI":"10.1016\/S0021-9258(17)44829-0","article-title":"Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.","volume":"254","author":"Pedersen","year":"1990","journal-title":"J Biol Chem."},{"key":"2020021219441875300_B14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev.bi.61.070192.000511","article-title":"Biochemical insights derived from insect diversity.","volume":"61","author":"Law","year":"1992","journal-title":"Annu Rev Biochem."},{"key":"2020021219441875300_B15","doi-asserted-by":"crossref","first-page":"10681","DOI":"10.1021\/bi973050y","article-title":"Nitrophorin-2: a novel mixed-type reversible specific inhibitor of the intrinsic factor-X activating complex.","volume":"37","author":"Zhang","year":"1998","journal-title":"Biochemistry."},{"key":"2020021219441875300_B16","doi-asserted-by":"crossref","first-page":"11209","DOI":"10.1021\/bi990761i","article-title":"Purification, cloning, and synthesis of a novel salivary anti-thrombin from the mosquito Anopheles albimanus.","volume":"38","author":"Valenzuela","year":"1999","journal-title":"Biochemistry."},{"key":"2020021219441875300_B17","doi-asserted-by":"crossref","first-page":"16674","DOI":"10.1021\/bi991231p","article-title":"Anophelin: kinetics and mechanism of thrombin inhibition.","volume":"38","author":"Francischetti","year":"1999","journal-title":"Biochemistry."},{"key":"2020021219441875300_B18","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0014-4894(90)90121-R","article-title":"Saliva of the tick Ixodes dammini inhibits neutrophil function.","volume":"70","author":"Ribeiro","year":"1990","journal-title":"Exp Parasitol."},{"key":"2020021219441875300_B19","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1074\/jbc.M001486200","article-title":"Purification, cloning, and expression of a novel salivary anticomplement protein from the tick, Ixodes scapularis.","volume":"275","author":"Valenzuela","year":"2000","journal-title":"J Biol Chem."},{"key":"2020021219441875300_B20","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1084\/jem.161.2.332","article-title":"Antihemostatic, anti-inflammatory, and immunosuppressive properties of the saliva of a tick, Ixodes dammini.","volume":"161","author":"Ribeiro","year":"1985","journal-title":"J Exp Med."},{"key":"2020021219441875300_B21","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1016\/S0021-9258(17)37432-X","article-title":"Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata.","volume":"269","author":"Karczewski","year":"1994","journal-title":"J Biol Chem."},{"key":"2020021219441875300_B22","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1002\/j.1460-2075.1996.tb00989.x","article-title":"The ornithodorin-thrombin crystal structure, a key to the TAP enigma?","volume":"15","author":"Locht","year":"1996","journal-title":"EMBO J."},{"key":"2020021219441875300_B23","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.2333510","article-title":"Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation FXa.","volume":"248","author":"Waxman","year":"1990","journal-title":"Science."},{"key":"2020021219441875300_B24","first-page":"3","article-title":"Coagulation cascade: an overview.","volume-title":"Thrombosis and Hemorrhage.","author":"Jenny","year":"1998","edition":"2nd ed."},{"key":"2020021219441875300_B25","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1021\/bi00107a001","article-title":"The coagulation cascade: initiation, maintenance, and regulation.","volume":"30","author":"Davie","year":"1991","journal-title":"Biochemistry."},{"key":"2020021219441875300_B26","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2307\/3276849","article-title":"A modified method for obtaining tick oral secretion.","volume":"53","author":"Tatchell","year":"1967","journal-title":"J Parasitol."},{"key":"2020021219441875300_B27","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","article-title":"Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.","volume":"25","author":"Altschul","year":"1997","journal-title":"Nucl Acids Res."},{"key":"2020021219441875300_B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/protein\/10.1.1","article-title":"A neural network method for identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites.","volume":"10","author":"Nielsen","year":"1997","journal-title":"Protein Eng."},{"key":"2020021219441875300_B29","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucl Acids Res."},{"key":"2020021219441875300_B30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0076-6879(79)63019-7","article-title":"The kinetics of reversible tight-binding inhibition.","volume":"63","author":"Williams","year":"1979","journal-title":"Methods Enzymol."},{"key":"2020021219441875300_B31","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1016\/S0021-9258(18)45150-2","article-title":"The active site of blood coagulation FXa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex.","volume":"262","author":"Husten","year":"1987","journal-title":"J Biol Chem."},{"key":"2020021219441875300_B32","doi-asserted-by":"crossref","first-page":"10063","DOI":"10.1074\/jbc.M009116200","article-title":"Role of zymogen and activated FX as scaffolds for the inhibition of the blood coagulation FVIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.","volume":"276","author":"Bergun","year":"2001","journal-title":"J Biol Chem."},{"key":"2020021219441875300_B33","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1021\/bi00492a016","article-title":"Proteolytic activation of human factors IX and X by recombinant human FVIIa: effects of calcium, phospholipids, and tissue factor.","volume":"29","author":"Komiyama","year":"1991","journal-title":"Biochemistry."},{"key":"2020021219441875300_B34","first-page":"261","article-title":"Recombinant FIX.","volume":"78","author":"White","year":"1997","journal-title":"Thrombos Hemost."},{"key":"2020021219441875300_B35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V86.2.436.bloodjournal862436","article-title":"Pyrrolidine dithiocarbamate abrogates tissue factor (TF) expression by endothelial cells: evidence implicating nuclear factor-kB in TF induction by diverse agonists.","volume":"86","author":"Orthner","year":"1995","journal-title":"Blood."},{"key":"2020021219441875300_B36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0022-2836(74)90163-6","article-title":"Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor, II: crystallographic refinement at 1.9 A resolution.","volume":"89","author":"Huber","year":"1974","journal-title":"J Mol Biol."},{"key":"2020021219441875300_B37","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1021\/bi000182+","article-title":"The tissue factor region that interacts with substrates FIX and FX.","volume":"3","author":"Kirchhofer","year":"2000","journal-title":"Biochemistry."},{"key":"2020021219441875300_B38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/bi002013v","article-title":"The tissue factor region that interacts with FXa in the activation of FVII.","volume":"40","author":"Kirchhofer","year":"2001","journal-title":"Biochemistry."},{"key":"2020021219441875300_B39","doi-asserted-by":"crossref","first-page":"14379","DOI":"10.1073\/pnas.93.25.14379","article-title":"Identification of surface residues mediating tissue factor binding and catalytic function of the serine protease FVIIa.","volume":"93","author":"Dickinson","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021219441875300_B40","doi-asserted-by":"crossref","first-page":"28826","DOI":"10.1074\/jbc.M005266200","article-title":"Exosite interactions determine the affinity of FX for the extrinsic Xase complex.","volume":"275","author":"Baugh","year":"2000","journal-title":"J Biol Chem."},{"key":"2020021219441875300_B41","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1182\/blood.V79.8.2004.2004","article-title":"Tissue factor pathway inhibitor: the carboxy-terminus is required for optimal inhibition of FXa.","volume":"79","author":"Wesselschmidt","year":"1992","journal-title":"Blood."},{"key":"2020021219441875300_B42","first-page":"1173","article-title":"The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.","volume":"95","author":"Warshawasky","year":"1995","journal-title":"J Clin Invest."},{"key":"2020021219441875300_B43","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1182\/blood.V95.6.1973","article-title":"Recombinant full-length tissue factor pathway inhibitor fails to bind to the cell surface: implications for catabolism in vitro and in vivo.","volume":"95","author":"Ho","year":"2000","journal-title":"Blood."},{"key":"2020021219441875300_B44","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1432-1033.1996.0310f.x","article-title":"Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissue-factor-pathway inhibitor.","volume":"235","author":"Petersen","year":"1996","journal-title":"Eur J Biochem."},{"key":"2020021219441875300_B45","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1074\/jbc.275.5.3320","article-title":"Identification of basic residues in the heparin-binding exosite of FXa critical for heparin and factor Va binding.","volume":"275","author":"Rezaie","year":"2000","journal-title":"J Biol Chem."},{"key":"2020021219441875300_B46","doi-asserted-by":"crossref","first-page":"12080","DOI":"10.1021\/bi970979+","article-title":"Exosites determine macromolecular substrate recognition by prothrombinase.","volume":"36","author":"Krishnaswamy","year":"1997","journal-title":"Biochemistry."},{"key":"2020021219441875300_B47","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1093\/emboj\/16.17.5151","article-title":"X-ray structure of antistasin at 1.9 A resolution and its modeled complex with blood coagulation FXa.","volume":"16","author":"Lapatto","year":"1997","journal-title":"EMBO J."},{"key":"2020021219441875300_B48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1099-1352(200101\/02)14:1<42::AID-JMR518>3.0.CO;2-8","article-title":"Recognition between flexible protein molecules: induced and assisted folding.","volume":"14","author":"Demchenko","year":"2001","journal-title":"J Mol Recognit."},{"key":"2020021219441875300_B49","doi-asserted-by":"crossref","first-page":"16428","DOI":"10.1074\/jbc.M001254200","article-title":"Characterization of proexosite I on prothrombin.","volume":"275","author":"Anderson","year":"2000","journal-title":"J Biol Chem."},{"key":"2020021219441875300_B50","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1021\/bi982254r","article-title":"Importance of FVIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate FX Gla-domain.","volume":"38","author":"Ruf","year":"1999","journal-title":"Biochemistry."},{"key":"2020021219441875300_B51","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1021\/bi970388j","article-title":"Potent bifunctional anticoagulants: Kunitz domain-tissue factor fusion proteins.","volume":"36","author":"Lee","year":"1997","journal-title":"Biochemistry."},{"key":"2020021219441875300_B52","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1126\/science.1972598","article-title":"Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein.","volume":"248","author":"Girard","year":"1990","journal-title":"Science."},{"key":"2020021219441875300_B53","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1073\/pnas.93.5.2149","article-title":"Anticoagulant repertoire of the hookworm Ancylostoma caninum.","volume":"93","author":"Stassens","year":"1996","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021219441875300_B54","doi-asserted-by":"crossref","first-page":"95S","DOI":"10.1378\/chest.119.1_suppl.95S","article-title":"New anticoagulant drugs.","volume":"119","author":"Weitz","year":"2001","journal-title":"Chest."},{"key":"2020021219441875300_B55","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-0038-1657572","article-title":"Tissue factor pathway inhibitor: potential therapeutic applications.","volume":"78","author":"Bajaj","year":"1997","journal-title":"Thromb Haemost."},{"key":"2020021219441875300_B56","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1182\/blood.V75.7.1481.1481","article-title":"Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity.","volume":"75","author":"Warr","year":"1990","journal-title":"Blood."},{"key":"2020021219441875300_B57","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1161\/01.ATV.19.10.2563","article-title":"Structural requirements for TFPI-mediated inhibition of neointimal thickening after balloon injury in the rat.","volume":"19","author":"Han","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"2020021219441875300_B58","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood.V95.4.1124.002k20_1124_1129","article-title":"Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.","volume":"95","author":"Jonge","year":"1999","journal-title":"Blood."},{"key":"2020021219441875300_B59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/hc2601.091386","article-title":"A dose-response study of recombinant FVIIa\/TF inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.","volume":"104","author":"Lee","year":"2001","journal-title":"Circulation."},{"key":"2020021219441875300_B60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2007-999011","article-title":"Pharmacological profiling of recombinant tissue factor pathway inhibitor.","volume":"22","author":"Jeske","year":"1996","journal-title":"Semin Thromb Hemost."},{"key":"2020021219441875300_B61","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1055\/s-0038-1657701","article-title":"Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function.","volume":"78","author":"Himber","year":"1997","journal-title":"Thromb Haemost."},{"key":"2020021219441875300_B62","first-page":"76","article-title":"Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway.","volume":"26","author":"Harker","year":"1996","journal-title":"Haemostasis."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/10\/3602\/1684693\/h81002003602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/10\/3602\/1684693\/h81002003602.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T09:23:03Z","timestamp":1622020983000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/10\/3602\/106983\/Ixolaris-a-novel-recombinant-tissue-factor-pathway"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5,15]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,5,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2001-12-0237","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,5,15]]}}}